Artelo biosciences completes enrollment of the phase 1b stage of its cares clinical trial evaluating art27.13 for the treatment of cancer-related anorexia and weight loss

Expects to commence phase 2a of cares during the first quarter of 2023 expects to commence phase 2a of cares during the first quarter of 2023

ARTL Ratings Summary

ARTL Quant Ranking